Willow Biosciences Inc.
CANSF
$0.0038
$0.001140.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 64.00% | 45.08% | 54.04% | 50.41% | 48.63% |
| Total Depreciation and Amortization | 92.27% | -44.66% | -21.94% | -21.87% | -16.74% |
| Total Amortization of Deferred Charges | -34.85% | -- | -- | -- | -80.92% |
| Total Other Non-Cash Items | -141.40% | 138.61% | -20.00% | -87.93% | -58.37% |
| Change in Net Operating Assets | -74.01% | 62.75% | 163.86% | 569.97% | 1,328.35% |
| Cash from Operations | 71.36% | 62.02% | 80.46% | 54.05% | 72.67% |
| Capital Expenditure | 100.00% | 34.38% | -- | -- | -117.39% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -91.34% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.41% | -648.74% | -- | -- | 101.13% |
| Cash from Investing | 743.18% | -668.27% | -- | -96.10% | 100.17% |
| Total Debt Issued | -482.77% | 263.12% | -- | -- | -- |
| Total Debt Repaid | -38.22% | 52.29% | 13.79% | -13.79% | 1.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8,156.52% | -25,200.00% | 98.44% | -- | 2,200.00% |
| Cash from Financing | -180.76% | 650.99% | 214.80% | 140.98% | 271.10% |
| Foreign Exchange rate Adjustments | 169.26% | 28.85% | 118.59% | 182.21% | -111.78% |
| Miscellaneous Cash Flow Adjustments | -- | 278.74% | -- | -- | -- |
| Net Change in Cash | 4.25% | 105.96% | 77.18% | -183.84% | 92.82% |